The forecast for the sold production of medicaments of other antibiotics not packaged for retail sale in Italy indicates a downward trend from 2024 to 2028, starting at €67.739 million in 2024 and falling to €49.918 million by 2028. This represents a compound annual growth rate (CAGR) of approximately -7.5% across the five years. Year-on-year declines highlight this trend, with a consistent drop of about 6-8% each year. When assessing this forecast data, it's essential to remember that production in 2023 stood at €72.5 million, reinforcing the declining trajectory.
Future trends to watch include potential impacts from regulatory changes, technological advancements in drug production, shifts in antibiotic usage patterns, and fluctuations in global market demand. Close attention should be paid to health policies that may influence antibiotic production or introduce new competitive pressures in the pharmaceutical industry.
